FDA recalls expectorant capsules with dissolution problems

Approximately 110,000 capsules of prescription drug expectorant have been ordered removed from pharmacy shelves after reporting poor dissolution, Taiwan's Food and Drug Administration (FDA) announced Wednesday.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)